Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens-Reference-Cited by-同舟云学术

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens

Published:2016-02-12 Issue:2 Volume:11 Page:e0148924
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

López-Cortés Luis F.,Castaño Manuel A.,López-Ruz Miguel A.,Rios-Villegas María J.,Hernández-Quero José,Merino Dolores,Jiménez-Aguilar Patricia,Marquez-Solero Manuel,Terrón-Pernía Alberto,Tellez-Pérez Francisco,Viciana Pompeyo,Orihuela-Cañadas Francisco,Palacios-Baena Zaira,Vinuesa-Garcia David,Fajardo-Pico Jose M.,Romero-Palacios Alberto,Ojeda-Burgos Guillermo,Pasquau-Liaño Juan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy;DV Havlir;N Engl J Med,1998

2. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients;G Pialoux;N Engl J Med,1998

3. Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study;MH Reijers;Lancet,1998

4. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study);JR Arribas;J Acquir Immune Defic Syndr,2005

5. Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression;F Pulido;J Antimicrob Chemother,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune recovery among Romanian HIV/AIDS patients receiving darunavir/ritonavir or darunavir/cobicistat regimens in cART management: A three-year study;Biomedicine & Pharmacotherapy;2023-05

2. Virologic status and pattern of drug resistance mutation among ART-experienced HIV-infected patients in Butuo County, China;Journal of Global Antimicrobial Resistance;2023-03

3. Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial;Clinical Microbiology and Infection;2022-08

4. Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib;Pharmaceutical Research;2022-03-29

5. Factors associated with the number of drugs in darunavir/cobicistat regimens;Journal of Antimicrobial Chemotherapy;2019-10-05